ישראל -
עברית -
Ministry of Health
dental implants and recovery accessories
cortex dental implants industries ltd. - רופא שיניים - the cortex dental implants system is indicated for use in surgical and restorative applications for placement in the maxillary and/or mandibular arches to provide support for prosthetic restorations in edentulous or partially edentulous patients. the cortex implants are for single-stage or two-stage surgery.
ישראל -
עברית -
Ministry of Health
dental implant+tools
cortex dental implants industries ltd. - רופא - טיפולים שיקומיים בפה
ישראל -
עברית -
Ministry of Health
locator
cortex dental implants industries ltd. - רופא שיניים - חיבור בן המבנה לתותבת
ישראל -
עברית -
Ministry of Health
קזודקס 50 מג
taro international ltd, israel - bicalutamide - טבליה - bicalutamide 50 mg - bicalutamide - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.
ישראל -
עברית -
Ministry of Health
קורטקס-שמפו בוץ מינרלי עם שמן אובליפיחה
א. משי תעשיות בעמ - חפיפת שיער
ישראל -
עברית -
Ministry of Health
implantable radioactive device + accessories
lavi industrial & medical agencies ltd. - מומחה - treatment of liver tumours / liver cancer
ישראל -
עברית -
Ministry of Health
איקסמפרה 15 מ"ג
bristol-myers squibb (israel) limited - ixabepilone 15 mg - powder for concentrate for infusion - ixabepilone - ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:in combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.as monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.
ישראל -
עברית -
Ministry of Health
איקסמפרה 45 מ"ג
bristol-myers squibb (israel) limited - ixabepilone 45 mg - powder for concentrate for infusion - ixabepilone - ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:in combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.as monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom further anthracycline therapy is not indicated.